Fermer le menu


Member of Lyonbiopole


Holding with major stakes in the bioindustrial companies bioMérieux (diagnostics), Transgene (immunotherapy) and Mérieux NuriSciences (food safety and quality controls, nutrition) and also  in the R&D company ABL, and in the invesment company Mérieux Développement


Strategic application domain: Human Medicine

Application market: Cardiology, Infectious Diseases, Oncology

Type of activity: Diagnostics, Therapeutics, Pharma or Biotech

Technologies: Vaccine, Others

Created on nov. 10th, 1897 - 15000 employees



17 rue Bourgelat 69002 LYON



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.